Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Presynaptic membrane receptors are specialized proteins located on the axonal terminals of neurons, where they serve as essential regulators of synaptic transmission (StatPearls, 2023). These receptors function by monitoring the chemical environment of the synaptic cleft and providing feedback to the neuron to either inhibit or enhance the further release of neurotransmitters (NCBI Bookshelf, 2021). They are broadly classified into autoreceptors, which respond to the neuron's own released transmitter, and heteroreceptors, which respond to transmitters from neighboring neurons (PubMed, 2019). Most presynaptic receptors are G-protein-coupled receptors (GPCRs) that influence ion channel activity, particularly by inhibiting voltage-gated calcium channels or activating potassium channels to hyperpolarize the terminal (Journal of Neuroscience, 2020). By modulating the influx of ions, these receptors effectively control the probability of vesicle fusion and neurotransmitter exocytosis. Because they control the gain of neuronal signaling, they are vital therapeutic targets for a wide range of conditions, including depression, Parkinson's disease, and chronic pain (Nature Reviews Neuroscience, 2022). Drugs targeting these receptors can either mimic natural ligands to reduce overactive signaling or block them to enhance neurotransmission in depleted states. Overall, presynaptic receptors represent a sophisticated mechanism for maintaining homeostatic balance within the central and peripheral nervous systems.
Drugs targeting these receptors typically act as agonists to trigger feedback inhibition of neurotransmitter release or as antagonists to block this inhibition and increase neurotransmitter levels in the synapse (StatPearls, 2023).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Presynaptic membrane receptor.